APA (7th ed.) Citation

Christopoulos, P., Dietz, S., Kirchner, M., Volckmar, A., Endris, V., Neumann, O., . . . Stenzinger, A. (2019). Detection of TP53 mutations in tissue or liquid rebiopsies at progression identifies ALK+ lung cancer patients with poor survival. Cancers, 11(1), . https://doi.org/10.3390/cancers11010124

Chicago Style (17th ed.) Citation

Christopoulos, Petros, et al. "Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor Survival." Cancers 11, no. 1 (2019). https://doi.org/10.3390/cancers11010124.

MLA (9th ed.) Citation

Christopoulos, Petros, et al. "Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor Survival." Cancers, vol. 11, no. 1, 2019, https://doi.org/10.3390/cancers11010124.